SEARCH

SEARCH BY CITATION

References

  • 1
    Hatlebakk JG & Berstad A. Endoscopic grading of reflux oesophagitis: What observations correlate with gastro-oesophageal reflux? Scand J Gastroenterol 1997; 32: 760 5.
  • 2
    Robertson D, Aldersley M, Shepherd H, Smith CL. Patterns of reflux in complicated oesophagitis. Gut 1987; 28: 1184 8.
  • 3
    Gonvers J-J, Zellweger J-P, Leuenbergher P, Fraser R. Asthma, respiratory disease and gastro-oesophageal reflux. Gullet 1993; 3(Suppl.): 53 9.
  • 4
    Bell NJV & Hunt RH. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 1992; 33: 118 24.
  • 5
    Klinkenberg-Knol EC & Meuwissen SGM. Combined gastric and oesophageal 24-hour pH-monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990; 4: 485 95.
  • 6
    Peghini PL, Katz PO, Bracy N, Castell DO. Nocturnal recovery of gastric acid secretion with twice daily dosing of proton pump inhibitors. Am J Gastroenterol 1998; 93: 763 7.
    Direct Link:
  • 7
    Katzka DA & Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett’s esophagus. Am J Gastroenterol 1994; 89: 989 91.
  • 8
    Castell DO & Castell JA (eds). Esophageal Motility Testing, 2nd edn. Norwalk: Appleton & Lange, 1994: 32–33.
  • 9
    Castell JA. Esophageal manometry. In: Castell DO, ed. The Esophagus, 2nd edn. Boston: Little, Brown and Company, 1995: 133–52.
  • 10
    Ter RB, Johnston BT, Castell DO. Exclusion of the meal period improves the clinical reliability of esophageal pH monitoring. J␣Clin Gastroenterol 1997; 25: 314 16.
  • 11
    Prichard PJ, Yeomans ND, Mihaly GW, et al. Omeprazole: A study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 1985; 88: 64 9.
  • 12
    Hatlebakk JG, Katz PO, Castell DO. Proton pump inhibitors should be taken with meals for optimal control of gastric acidity. Gastroenterology 1998; 114: A144 5(Abstract).
  • 13
    Khoury R, Mohiuddin M, Katz P, Castell DO. Influence of body position on nighttime recumbent reflux in patients with GERD. Gastroenterology 1998; 114: A174(Abstract).
  • 14
    Hendel J, Hendel L, Aggestrup S. Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 1995; 9: 693 7.
  • 15
    Hatlebakk JG & Berstad A. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Clin Pharmacokinet 1996; 31: 386 406.
  • 16
    Hirschowitz BI. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 1991; 101: 1149 58.
  • 17
    Bell NJV, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992; 51(Suppl. 1): 59 67.
  • 18
    Hatlebakk JG & Berstad A. Gastro-esophageal reflux during three months of therapy with ranitidine in reflux esophagitis. Scand J Gastroenterol 1996; 31: 954 8.
  • 19
    Moore JG & Englert E. Circadian rhythm of gastric acid secretion in man. Nature 1970; 226: 1264 5.
  • 20
    Moore JG & Wolfe M. The relation of plasma gastrin to the circadian rhythm of gastric acid secretion in man. Digestion 1973; 9: 97 105.
  • 21
    Waldum HL, Amestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996; 39: 649 53.
  • 22
    Sandvik AK, Brenna E, Waldum HL. Review article: The pharmacological inhibition of gastric acid secretion—tolerance and rebound. Aliment Pharmacol Ther 1997; 11: 1013 18.
  • 23
    Peghini P, Katz P, Gilbert J, Castell D. Ranitidine controls nocturnal gastric acid breakthrough during BID proton pump inhibitor treatment. Am J Gastroenterol 1997; 92: 1600.
  • 24
    Emde C, Garner A, Blum AL. Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut 1987; 28: 1177 88.
  • 25
    Armstrong D, Emde C, Blum AL. Twenty-four-hour intragastric pH-metry studies: easy to do but difficult to analyse. Eur J Gastroenterol Hepatol 1989; 1: 167 74.
  • 26
    Pursnani KG, Mohiuddin MA, Geisinger KR, Weinbaum G, Castell DO. Quantitative evaluation of the role of ‘acid-burden’ in production of feline esophagitis. Gastroenterology 1996; 110: A235(Abstract).
  • 27
    Lacey Smith J, Opekun AR, Larkai E, Graham DY. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989; 96: 683 9.